These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29620693)

  • 1. Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar Disorder.
    Miller S; Do D; Gershon A; Wang PW; Hooshmand F; Chang LS; Ketter TA
    J Clin Psychopharmacol; 2018 Jun; 38(3):207-211. PubMed ID: 29620693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
    DelBello MP; Tocco M; Pikalov A; Deng L; Goldman R
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):494-503. PubMed ID: 34324397
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP; Sajatovic M; Tsai J; Pikalov A; Cucchiaro J; Loebel A
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):150-159. PubMed ID: 29146409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study.
    Citrome L; Weiden PJ; McEvoy JP; Correll CU; Cucchiaro J; Hsu J; Loebel A
    CNS Spectr; 2014 Aug; 19(4):330-9. PubMed ID: 24330868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA; Sarma K; Silva R; Kroger H; Cucchiaro J; Loebel A
    Depress Anxiety; 2016 May; 33(5):424-34. PubMed ID: 26918425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 7. Lurasidone: an antipsychotic with antidepressant effects in bipolar depression?
    Keks NA; Hope J; Castle D
    Australas Psychiatry; 2016 Jun; 24(3):289-91. PubMed ID: 27036122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorder.
    Dell'osso B; Timtim S; Hooshmand F; Miller S; Wang PW; Hill SJ; Portillo N; Ketter TA
    J Affect Disord; 2013 Aug; 150(1):130-5. PubMed ID: 23261131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M; Forester BP; Tsai J; Kroger H; Pikalov A; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2016 Oct; 77(10):e1324-e1331. PubMed ID: 27529375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.
    DelBello MP; Goldman R; Phillips D; Deng L; Cucchiaro J; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2017 Dec; 56(12):1015-1025. PubMed ID: 29173735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression: A 12-Week Observational Study.
    Takaesu Y; Takeshima M; Watanabe K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):485-488. PubMed ID: 35916577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
    Miller S; Ittasakul P; Wang PW; Hill SJ; Childers ME; Rasgon N; Ketter TA
    J Clin Psychopharmacol; 2012 Dec; 32(6):814-9. PubMed ID: 23131875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
    Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
    World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study.
    Yatham LN; Mackala S; Basivireddy J; Ahn S; Walji N; Hu C; Lam RW; Torres IJ
    Lancet Psychiatry; 2017 Mar; 4(3):208-217. PubMed ID: 28185899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of lurasidone for bipolar depression.
    Loebel A; Xu J; Hsu J; Cucchiaro J; Pikalov A
    Ann N Y Acad Sci; 2015 Nov; 1358():95-104. PubMed ID: 26771990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder.
    Schaffer CB; Schaffer LC; Nordahl TE; Stark NM; Gohring CE
    J Clin Psychopharmacol; 2016 Feb; 36(1):88-9. PubMed ID: 26650972
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression.
    Kato T; Ishigooka J; Miyajima M; Watabe K; Fujimori T; Masuda T; Higuchi T; Vieta E
    Psychiatry Clin Neurosci; 2020 Dec; 74(12):635-644. PubMed ID: 32827348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.
    Rajagopalan K; Meyer K; O'Day K; Denno M; Loebel A
    J Med Econ; 2015; 18(10):821-7. PubMed ID: 25985265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.